Showing results (11-20 of 36) with videos related to

Sort By:
Pageof 4
Investigational New Drugs|May 17, 2020
Real-world assessment of afatinib for patients with EGFR-positive non-small cell lung cancerSatoshi Igawa, Taihei Ono, Masashi Kasajima, et al.
Investigational New Drugs|May 4, 2017
Phase I study of Nedaplatin, a platinum based antineoplastic drug, combined with nab-paclitaxel in patients with advanced squamous non-small cell lung cancerSatoshi Igawa, Sakiko Otani, Yoshiro Nakahara, et al.
Investigational New Drugs|June 21, 2017
Phase II study of Amrubicin monotherapy in elderly or poor-risk patients with extensive disease of small cell lung cancerSatoshi Igawa, Sakiko Otani, Shinichiro Ryuge, et al.
Clinical Lung Cancer|May 28, 2018
Activity of Nivolumab and Utility of Neutrophil-to-Lymphocyte Ratio as a Predictive Biomarker for Advanced Non-Small-Cell Lung Cancer: A Prospective Observational StudyTomoya Fukui, Yuriko Okuma, Yoshiro Nakahara, et al.
Thoracic Cancer|January 17, 2019
Questionnaire survey on patient awareness of invasive rebiopsy in advanced non-small cell lung cancerTomoya Fukui, Mikiko Ishihara, Masashi Kasajima, et al.
Cancer Management and Research|December 1, 2021
A Prospective Observational Study of Osimertinib for Chemo-Naive Elderly Patients with EGFR Mutation-Positive Non-Small Cell Lung CancerSatoshi Igawa, Masashi Kasajima, Taihei Ono, et al.
Investigational New Drugs|March 12, 2020
Impact of neutrophil-to-lymphocyte ratio in patients with EGFR-mutant NSCLC treated with tyrosine kinase inhibitorsTaihei Ono, Satoshi Igawa, Shintaro Kurahayashi, et al.
Cancer Management and Research|December 13, 2018
Prognostic significance of the 8th edition of the TNM classification for patients with extensive disease small cell lung cancerMasayuki Shirasawa, Tomoya Fukui, Seiichiro Kusuhara, et al.
Oncology Reports|September 25, 2008
Metabolism of irinotecan and its active metabolite SN-38 by intestinal microflora in ratsMichiko Yamamoto, Akinobu Kurita, Takashi Asahara, et al.
Oncology|April 27, 2018
Smoking History as a Predictor of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Patients with Non-Small Cell Lung Cancer Harboring EGFR MutationsNoriko Nishinarita, Satoshi Igawa, Masashi Kasajima, et al.
Pageof 4